skip to main content
Idioma:
Refinado por: assunto: Delayed-Action Preparations remover assunto: Humans remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder
Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder

Schmith, Virginia D. ; Curd, Laura ; Lohmer, Lauren R. L. ; Laffont, Celine M. ; Andorn, Anne ; Young, Malcolm A.

Clinical pharmacology and therapeutics, 2019-09, Vol.106 (3), p.576-584 [Periódico revisado por pares]

United States: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
2
A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder

Kranzler, Henry R ; Lynch, Kevin G ; Crist, Richard C ; Hartwell, Emily ; Le Moigne, Anne ; Laffont, Celine M ; Andorn, Anne C

The international journal of neuropsychopharmacology, 2021-02, Vol.24 (2), p.89-96 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
3
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients

Walling, David P. ; Shinde, Sunita N. ; Pogoda, Janice M. ; Kharidia, Jahnavi ; Laffont, Celine M.

Clinical drug investigation, 2024-04, Vol.44 (4), p.251-260 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.